An extended minimum duration of immunity against panleucopaenia for up to 3 years from vaccination with Nobivac Tricat Trio means that on intervening years Ducat, a bivalent vaccine against the two viral causes of FURTD, may be administered as the booster vaccine. Ducat may also be given as early as 6 weeks when additional early protection against infectious respiratory disease is desired.
Lyophilisate and solvent for suspension for injection
Per dose of 1 ml reconstituted vaccine:
- Live attenuated feline viral rhinotracheitis virus, strain G2620A ≥ 4.8 log10 TCID50*
- Live attenuated feline calicivirus ≥ 4.6 log10 PFU**
*TCID50= Median Tissue Culture Infective Dose
** Plaque Forming Units
Indications for use
Nobivac Ducat is a live, attenuated vaccine (feline viral rhinotracheitis and feline calicivirus) and is indicated for the active immunisation of cats against feline viral rhinotracheitis (feline herpes virus type I) and feline calicivirus infections, vaccination with which reduces clinical signs caused by these viral infections. Nobivac Ducat can be used from as early as 6 weeks of age and can be used within a vaccination schedule in which feline panleucopaenia is administered every 3 years.
APET-plastic tray containing 10 or 50 single dose vials. Solvent may be packed together with the vaccine or separately.
Each vaccine vial contains a single dose for reconstitution with Nobivac Solvent (Vm 01708/4368) or Nobivac Rabies (Vm 01708/4325).
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018